...
【24h】

ACTH IN THE TREATMENT OF ERYTHROBLASTOSIS

机译:促肾上腺皮质激素治疗红细胞增生

获取原文
           

摘要

Twenty erythroblastotic infants were treated with ACTH. Immediately after delivery 12.5 mg. were given and 6.25 mg. every six hours thereafter for a median period of 8.5 days.These infants showed a delayed adrenal response as measured by a fall in the eosinophile count by the third day.As indicated by the reversal of the Coombs' test there was a sharp drop in the degree of sensitization of red cells in a shorter period than would have been expected naturally.The nucleated cell counts decreased to normal ranges by the fourth day chiefly because of the disappearance of erythroblasts.Red blood cell counts and hemoglobin determinations showed a tendency to rise during the period of ACTH administration and an invariable decrease when ACTH was discontinued.Hemolysis was certainly not completely prevented since most patients became clinically jaundiced and a concurrent rise in serum bilirubin was demonstrable.Four infants who had clinical erythroblastosis without demonstrable antibodies (negative Coombs' test) were treated with ACTH and responded in a similar manner.The Coombs' test became strongly positive in one patient after ACTH was discontinued on the tenth day. Serum bilirubin rose to 12 mg./100 cc. blood and the patient became clinically jaundiced. Fecal urobilinogen increased to 70 mg./24 hours on the fifteenth day. Administration of ACTH was resumed on the seventeenth day followed by a reversal of these processes.Antibiotic therapy was added to the study regime because of the possibility that ACTH may enhance infection in the newborn infant.A peculiar local reaction to pork ACTH was not noted with sheep ACTH.Three patients died, all on the third day. One of these patients was found to have kernicterus at autopsy. No surviving patient has any evidence of kernicterus.A much larger series will be required to demonstrate any effect on the mortality rate of erythroblastosis.Seven infants with mild erythroblastosis were not treated because the potential dangers of ACTH were considered to carry more risk than their state of the disease.Several modifications of the treatment regime used in this study are suggested.
机译:用促肾上腺皮质激素治疗20例成红细胞生成婴儿。分娩后立即服用12.5 mg。给予6.25毫克。此后每6小时进行一次,平均时间为8.5天。这些婴儿表现出的肾上腺反应延迟,这是通过到第三天时嗜酸性粒细胞计数的下降来衡量的。红细胞的致敏度比自然预期的要短。有核细胞数到第四天下降到正常范围,主要是由于成红细胞的消失;红细胞数和血红蛋白的测定在此期间呈上升趋势服用ACTH的时间段以及停用ACTH的时间不变地减少。由于大多数患者临床黄疸并且可证明血清胆红素同时升高,因此并不能完全防止溶血.4例临床上有成红细胞病且无明显抗体的婴儿(Coombs阴性试验) )接受ACTH治疗并以类似的方式反应。第十天停用ACTH后的一名患者中出现e。血清胆红素升至12 mg./100 cc。血液,患者临床黄疸。在第十五天,粪尿中尿胆素原增加到70 mg / 24小时。在第17天恢复服用ACTH,然后逆转这些过程。由于ACTH可能会增强新生婴儿的感染,因此在研究方案中增加了抗生素治疗,但未注意到对猪肉ACTH的特殊局部反应绵羊ACTH.3例患者在第三天全部死亡。其中一名患者在尸检时被发现患有角核。尚存的患者没有任何核仁的证据。将需要更大范围的研究以证明对成红细胞病的死亡率有任何影响。未治疗7例轻度成红细胞病的婴儿,因为ACTH的潜在危险被认为比其状态更具风险建议对本研究中使用的治疗方案进行一些修改。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号